About Malecare

This author has not yet filled in any details.
So far Malecare has created 608 blog entries.

Before You Rush Into Surgery . . .

Hi Folks, Prostate surgery, especially, robotic, is fast becoming the one-size-fits-all treatment recommendation for newly diagnosed patients. I suggest you don't rush into surgery or anything else. The first thing to do is assemble a brain trust, i.e., put together a list of the the best doctors in the world that you have access to. [...]

S.T.A.R. Program press release

This a an example of what can happen when collaborations happen for prostate cancer research.  Advocates can help facilitate by raising funds or beginning discussions. WASHINGTON, Nov. 15 /PRNewswire-USNewswire/ -- Safeway Inc. and the Prostate Cancer Foundation today announced they will collectively donate $6 million to fund the S.T.A.R. Program (for Special Team Amplification of [...]

By |2020-02-04T12:23:07-05:00November 15th, 2007|Activism, Treatment News|1 Comment

Improving Health Care Quality and Value

Changes in the health care delivery system and cost control are issues that are being discussed now in the United States. As we get closer to the election the issue will become more important in political debates. Now is the time for prostate cancer advocates to learn about some of the options that are being [...]

By |2020-02-04T08:35:24-05:00November 14th, 2007|Activism, Treatment News|0 Comments

Your action is necessary today

You can help save prostate cancer research funding. Yesterday, President Bush vetoed the Fiscal Year (FY) 2008 Labor, Health and Human Services (Labor-HHS) appropriations bill (HR 3043) that Congress passed last week. The Labor-HHS appropriations bill would not only reverse the President's planned $480 million cut to the National Institutes of Health (NIH), it provides [...]

By |2021-02-17T11:03:07-05:00November 14th, 2007|Activism|0 Comments

Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs)

The FDA press release below is important to some men with prostate cancer. If you are currently taking Aranesp, Epogen or Procrit you should talk to your doctor about your risks and potential benefits. FDA Strengthens Boxed Warnings, Approves Other Safety Labeling Changes for Erythropoiesis-Stimulating Agents (ESAs) The U.S. Food and Drug Administration today approved [...]

By |2017-10-19T10:58:55-04:00November 14th, 2007|Activism, Treatment News|0 Comments
Go to Top